(Q44249053)

1 December 2017

title

Selection of chemotherapy by ex vivo assessment of tumor sensitivity to cytotoxic drugs: results of a clinical trial (English)

1 reference

1 December 2017

0 references

1 reference

Bengt Glimelius

1 reference

1 December 2017

Peter Nygren

1 reference

1 December 2017

Rolf Larsson

1 reference

1 December 2017

Anne von Heideman

1 reference

1 December 2017

Bengt Tholander

1 reference

1 December 2017

Hans Hagberg

1 reference

1 December 2017

Ake Berglund

1 reference

1 December 2017

Jonas Bergh

1 reference

1 December 2017

Ola Brodin

1 reference

1 December 2017

Marie-Louise Fjällskog

1 reference

1 December 2017

Manuel de la Torre

1 reference

1 December 2017

Gunnar Aström

1 reference

1 December 2017

Kjell Oberg

1 reference

1 December 2017

Gunnar Parö

1 reference

1 December 2017

publication date

1 January 2002

1 reference

1 December 2017

1 reference

1 December 2017

1 reference

1 December 2017

1 reference

1 December 2017

page(s)

151-159

1 reference

Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial. Scandinavian Breast Group 9401 study.

1 December 2017

cites work

1 reference

12 December 2020

Review of the efficacy of individualized chemotherapy selected by in vitro drug sensitivity testing for patients with cancer

1 reference

12 December 2020

Relationship between pharmacokinetic parameters in patients and cytotoxicity in vitro of standard and investigational anticancer drugs

1 reference

12 December 2020

Detection of tumor-specific cytotoxic drug activity in vitro using the fluorometric microculture cytotoxicity assay and primary cultures of tumor cells from patients

1 reference

12 December 2020

Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative

1 reference

12 December 2020

Phase I trial of cremophor EL with bolus doxorubicin.

1 reference

12 December 2020

College of American Pathologists Conference XXXV: solid tumor prognostic factors-which, how and so what? Summary document and recommendations for implementation. Cancer Committee and Conference Participants

1 reference

12 December 2020

The polyoxyethylene castor oil Cremophor EL modifies multidrug resistance

1 reference

12 December 2020

Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer

1 reference

12 December 2020

Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia

1 reference

12 December 2020

In vitro drug sensitivity testing of tumor cells from patients with non-Hodgkin's lymphoma using the fluorometric microculture cytotoxicity assay

1 reference

12 December 2020

Measurement of cremophor EL following taxol: plasma levels sufficient to reverse drug exclusion mediated by the multidrug-resistant phenotype

1 reference

12 December 2020

In vitro determination of cytotoxic drug response in ovarian carcinoma using the fluorometric microculture cytotoxicity assay (FMCA)

1 reference

12 December 2020

Prediction of individual patient response to chemotherapy by the fluorometric microculture cytotoxicity assay (FMCA) using drug specific cut-off limits and a Bayesian model.

1 reference

12 December 2020

Clonogenic and nonclonogenic in vitro chemosensitivity assays

1 reference

12 December 2020

Cytotoxic drug sensitivity testing of tumor cells from patients with ovarian carcinoma using the fluorometric microculture cytotoxicity assay (FMCA).

1 reference

12 December 2020

What is cancer chemotherapy?

1 reference

12 December 2020

Disposition of Cremophor EL in humans limits the potential for modulation of the multidrug resistance phenotype in vivo

1 reference

12 December 2020

Laboratory prediction of clinical chemotherapeutic drug resistance: a working model exemplified by acute leukaemia

1 reference

12 December 2020

Feasibility of the fluorometric microculture cytotoxicity assay (FMCA) for cytotoxic drug sensitivity testing of tumor cells from patients with acute lymphoblastic leukemia

1 reference

12 December 2020

Taxol: the first of the taxanes, an important new class of antitumor agents.

1 reference

12 December 2020

Chemotherapeutic drug sensitivity testing of human leukemia cells in vitro using a semiautomated fluorometric assay

1 reference

12 December 2020

Reporting results of cancer treatment

1 reference

12 December 2020

The cytotoxic activity of Taxol in primary cultures of tumour cells from patients is partly mediated by Cremophor EL.

1 reference

12 December 2020

Lack of relationship between systemic exposure for the component drug of the fluorouracil, epirubicin, and 4-hydroxycyclophosphamide regimen in breast cancer patients

1 reference

12 December 2020

Laboratory determination of chemotherapeutic drug resistance in tumor cells from patients with leukemia, using a fluorometric microculture cytotoxicity assay (FMCA)

1 reference

12 December 2020

Diagnostics of malignant lymphomas with ultrasound guided 1.2 mm biopsy-gun

1 reference

12 December 2020

Identifiers

DOI

10.1385/MO:19:3:151

1 reference

Dimensions Publication ID

1 December 2017

1020054091

0 references

Fatcat ID

release_kiauc23mnzay5cigwk7siqtjfi

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kiauc23mnzay5cigwk7siqtjfi

24 November 2022

mapped directly with Wikidata item

1 reference